A

Albireo Pharma Inc
F:BDQM

Watchlist Manager
Albireo Pharma Inc
F:BDQM
Watchlist
Price: 41.41 EUR 0.46%
Market Cap: 857.2m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of BDQM.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BDQM Intrinsic Value
Not Available
A
Base Case Scenario
Compare BDQM to

Fundamental Analysis

Albireo Pharma Inc
F:BDQM
US
Biotechnology
Market Cap
856.9m EUR
IPO
May 11, 2007
US
Biotechnology
Market Cap
856.9m EUR
IPO
May 11, 2007
Price
€false
EPS
$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BDQM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Albireo Pharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Albireo Pharma Inc

Current Assets 238.8m
Cash & Short-Term Investments 222.5m
Receivables 2m
Other Current Assets 14.3m
Non-Current Assets 82.4m
PP&E 1.3m
Intangibles 17.3m
Other Non-Current Assets 63.8m
Efficiency

Free Cash Flow Analysis
Albireo Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Albireo Pharma Inc

Revenue
57.4m USD
Cost of Revenue
-2.5m USD
Gross Profit
54.8m USD
Operating Expenses
-177.8m USD
Operating Income
-122.9m USD
Other Expenses
-8.2m USD
Net Income
-131.1m USD
Fundamental Scores

BDQM Profitability Score
Profitability Due Diligence

Albireo Pharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Operating Margin is Increasing
Sustainable 3Y Average Gross Margin
23/100
Profitability
Score

Albireo Pharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

BDQM Solvency Score
Solvency Due Diligence

Albireo Pharma Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
55/100
Solvency
Score

Albireo Pharma Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BDQM Price Targets Summary
Albireo Pharma Inc

There are no price targets for BDQM.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BDQM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y